Premium
Selective versus exclusive use of sirolimus‐eluting stent implantation in multivessel coronary artery disease
Author(s) -
Chu William W.,
Rha SeungWoon,
Kuchulakanti Pramod K.,
Cheneau Edouard,
Torguson Rebecca,
Pakala Rajbabu,
Pinnow Ellen E.,
Pichard Augusto D.,
Satler Lowell F.,
Kent Kenneth M.,
Lindsay Joseph,
Waksman Ron
Publication year - 2005
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.20431
Subject(s) - medicine , restenosis , sirolimus , coronary artery disease , percutaneous coronary intervention , cardiology , stent , bare metal stent , drug eluting stent , myocardial infarction
Sirolimus‐eluting stents (SESs; Cypher) have demonstrated a significant reduction in restenosis rates when compared to bare metal stents (BMSs). The purpose of this study was to evaluate the strategy of exclusive use of two SESs versus the combination of one BMS and one SES for two‐vessel coronary artery disease (CAD). It was found that the selective use of one SES combined with one BMS in patients undergoing percutaneous coronary intervention that requires more than one stent is safe, feasible, and associated with favorable procedural, 30‐day, and 6‐month clinical outcomes when compared to the exclusive use of SESs. © 2005 Wiley‐Liss, Inc.